FDA warns doctors to stop using heart pump tied to deaths


In this Aug. 29, 2019 file photo, the Medronic logo is reflected in a lake at the company's offices in Fridley, Minn. On Thursday, June 3, 2021, U.S. health regulators warned surgeons to stop implanting an electrical heart pump made by Medtronic due to an electrical problem recently tied to cases of stroke and death. (AP Photo/Jim Mone, File)

WASHINGTON (AP) — U.S. health regulators warned surgeons Thursday to stop implanting a heart pump made by Medtronic due to power failures recently tied to cases of stroke and more than a dozen deaths.

Medtronic said earlier in the day it would stop selling its Heartware assist device, which is intended to boost blood circulation in patients with heart failure.

Recent company data showed the device can unexpectedly stop working and sometimes fail to restart, the Food and Drug Administration said. The company said it hasn't been able to pinpoint the root cause in every case.

Surgeons can use implants from other manufacturers, the FDA said in a memo to physicians.

About 4,000 people worldwide currently have the Medtronic device, roughly half of them in the U.S. For those patients, the agency said U.S. doctors should contact the company for the latest guidance on managing the device, which includes managing blood pressure.

The FDA said Medtronic halted sales after reviewing 100 reports of power failures with the device, which led to 14 patient deaths and 13 patients having it removed. The company previously issued recalls on some Heartware devices and components used when implanting it. In December, the company warned about power failures or delayed restarts with three lots.

The company said patients should not automatically have the device removed. Taking out recalled heart implants has to be carefully weighed against the potential risks of surgery. Medtronic said in a statement physicians should decide “on a case-by-case basis, considering the patients clinical condition and surgical risks.” The company said it is preparing a guide for managing patients “who may require support for many years.”

The Heartware device was used for heart failure patients awaiting transplant or as a permanent implant for those who weren’t healthy enough for that procedure. The device helps strengthen one of the heart's lower chambers needed for adequate blood circulation.


Medtronic is one of the world's largest medical device and equipment makers, selling thousands of implants used to treat heart, neurological and joint conditions.

___

The Associated Press Health & Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Should you invest $1,000 in Medtronic right now?

Before you consider Medtronic, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.

While Medtronic currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Medtronic (MDT)
4.5165 of 5 stars
$78.83-1.9%3.50%25.11Hold$94.91
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Search Headlines: